RESUMEN
BACKGROUND: To date there is no study that has estimated the prevalence of irritable bowel syndrome (IBS) in Germany according to the current Rome III criteria. The aim of the present study was to investigate the prevalence of IBS in a non-clinical German sample. Furthermore, we investigated the association of IBS with socio-demographic and psychological risk factors. METHODS: Baseline data from a prospective cohort study were analysed, including the IBS Module of the Rome III Diagnostic Questionnaires and validated psychometric scales including the Patient Health Questionnaire-15 (PHQ-15), the Big Five Inventory (BFI), the Perceived Stress Questionnaire (PSQ-5), and the Whiteley-Index (WI-7). The study population was compared to the German general population to appraise its representativeness. Multivariate logistic regression analyses were performed to identify possible risk factors associated with IBS. RESULTS: Between January 2011 and September 2012, 2419 persons participated (female 54.0â%, mean age 37.4â±â14.9 years). According to the Rome III criteria, 401 participants (16.6â%) suffered from IBS.âFive predictors were independently associated with IBS: previous traveller's diarrhoea infection (ORâ=â1.76; 95â% CIâ=â1.34 to 2.31), higher somatic symptom burden (ORâ=â1.15; 95â% CIâ=â1.07 to 1.23), increased level of hypochondriasis (ORâ=â2.04; 95â% CIâ=â1.54 to 2.70), increased vulnerability to diarrhoea under stress (ORâ=â3.88; 95â% CIâ=â3.21 to 4.68) and perceived stress (ORâ=â1.43; 95â% CIâ=â1.04 to 1.99). CONCLUSIONS: Our analyses yielded a relatively high IBS prevalence estimate, compared to studies published more than ten years ago. This might partially be explained by the fact that the time criterion of the Rome III criteria (at least 3 days/month in last 3 months) is more inclusive compared to the time criterion of the Rome II criteria (at least 12 weeks, which need not be consecutive, in the preceding 12 months).
Asunto(s)
Diarrea/epidemiología , Hipocondriasis/epidemiología , Síndrome del Colon Irritable/epidemiología , Síndrome del Colon Irritable/psicología , Estrés Psicológico/epidemiología , Adulto , Distribución por Edad , Comorbilidad , Diarrea/diagnóstico , Diarrea/psicología , Femenino , Alemania/epidemiología , Humanos , Hipocondriasis/diagnóstico , Hipocondriasis/psicología , Síndrome del Colon Irritable/diagnóstico , Masculino , Prevalencia , Factores de Riesgo , Distribución por Sexo , Estrés Psicológico/diagnóstico , Estrés Psicológico/psicología , Evaluación de Síntomas/estadística & datos numéricosRESUMEN
BACKGROUND: In 2011, a major outbreak of hemolytic-uremic syndrome (HUS) and bloody diarrhea related to infections from Shiga toxin-producing Escherichia coli O104 (STEC) occurred in Germany. While previous research has focused on the medical components of this disease, we aimed to investigate the course of health-related quality of life (HrQoL) over 12 months including somatic and psychosocial risk factors. Furthermore, the influence of chronic fatigue (CF) on HrQoL was examined. METHODS: A prospective cohort study with n = 389 patients completing self-report scales at baseline, after 6 months (participation rate: 79%) and after 12 months (participation rate: 77%). The courses of physical and mental HrQoL over the 12 month period were calculated by employing general linear mixed models. KEY RESULTS: While the physical component score of HrQoL reached a score comparable to the general population, the mental component score remained below average 12 months after STEC infection. Female gender, prior psychiatric disorder, and prior traumatic events were risk factors for a worse HrQoL course after 12 months, while social support was identified to be protective. CF was associated with low HrQoL. In addition, the somatic symptom burden remained persistently high. CONCLUSIONS & INFERENCES: Our results show high somatic and psychosocial burden in patients 12 months after STEC infection. We recommend considering the risk factors and protective factors of poor HrQoL early in the treatment of STEC or similar diseases. Patients who are suffering from persisting somatic symptoms, CF, and impaired HrQoL may require specific aftercare.